scorecardresearch

Sun Pharma raises Rs 1,000 crore via NCDs

NCDs will be listed on BSE under two series Sun Pharmaceutical Industries has raised Rs 1,000 crore through issuance of non-convertible debentures (NCDs) on private placement basis. “Sun Pharma Laboratories, a wholly-owned subsidiary of the company, has raised, on private placement basis, Rs 1,000 crore by allotment of 10,000 unsecured redeemable non-convertible debentures of a […]

NCDs will be listed on BSE under two series

Sun Pharmaceutical Industries has raised Rs 1,000 crore through issuance of non-convertible debentures (NCDs) on private placement basis.

“Sun Pharma Laboratories, a wholly-owned subsidiary of the company, has raised, on private placement basis, Rs 1,000 crore by allotment of 10,000 unsecured redeemable non-convertible debentures of a face value of Rs 10,00,000 each,” Sun Pharmaceutical Industries said.

It further said: “NCDs will be listed on BSE under two series with Series 1 debentures comprising 5,000 debentures amounting to Rs 500 crore with a tenor of 24 months, and Series 2 debentures comprising 5,000 debentures amounting to Rs 500 crore with a tenor of 39 months.”

The company did not elaborate on the usage of proceeds.

Get live Share Market updates and latest India News and business news on Financial Express. Download Financial Express App for latest business news.

First published on: 24-12-2015 at 16:53 IST